SG Americas Securities’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

SG Americas Securities’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,212	Closed	-$54K	–	3587
2023 Q4	$54K	Buy	+13,212	New	+$40.3K	﹤0.01%	2906

SG Americas Securities's THRX Position: Q1 2024 in Review

SG Americas Securities sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 13,212 shares — an estimated $54K sold.

SG Americas Securities first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $54K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

SG Americas Securities reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
SG Americas Securities sold 13,212 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $54K.
SG Americas Securities first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
SG Americas Securities's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $54K in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on SG Americas Securities's 13F filing for Q1 2024, filed 6 May 2024.